Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Asahimas Flat Glass Tbk (AMFG) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Asahimas Flat Glass TbkTrade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Asahimas Flat Glass Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Asahimas Flat Glass Tbk trades at Rp3,330 (market cap 1.44T, 5.3K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp165 (market cap 635.95B, 843K 24h volume). The key difference: Asahimas Flat Glass Tbk is far larger — about 2.3× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (843K versus 5.3K). Which is the better fit depends on your goals.

AMFGLABS
Market Cap
1.44T635.95B
Volume
5.3K843K
Lot
538.43K
Turnover
17.62M137.6M
Average Price
3,323.77163.22
Value
17.62M137.6M
Indicative Equilibrium Price
165
Indicative Equilibrium Volume
246

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

AMFG
View details
LABS
View details

About Asahimas Flat Glass Tbk

PT. Asahimas Flat Glass Tbk (The Company) was established within the foreign capital investment framework of Law No. 1 of 1967 and Law No. 11 of 1970, by deed of notary public Koerniatini Karim dated 7 October 1971 No. 4, as amended by deed of the same notary dated 6 January 1972 No. 9; these deeds were approved by the Minister of Justice under No. J.A.5/5/19 dated 17 January 1972. The Company is a joint venture between Asahi Glass of Japan and the Rodamas Group of Indonesia. Asahi Glass is one of the leading glass producers in the world.

Read more on AMFG

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS